- Investing Ideas
- /
- Hong Kong Big Pharma, Big Dividends
Hong Kong Big Pharma, Big Dividends
Results
5
Large pharmaceutical stocks to buy with strong dividend features.
5 companies
CSPC Pharmaceutical Group
Market Cap: HK$97.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.48
7D
-3.3%
1Y
84.7%
Sino Biopharmaceutical
Market Cap: HK$113.7b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$6.36
7D
-0.9%
1Y
107.8%
China Resources Pharmaceutical Group
Market Cap: HK$28.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.51
7D
-1.3%
1Y
-16.9%
China Medical System Holdings
Market Cap: HK$31.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.11
7D
0.4%
1Y
82.8%
Grand Pharmaceutical Group
Market Cap: HK$27.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$7.80
7D
-3.5%
1Y
69.6%